If you’re allergic to natural rubber latex, the Food and Drug Administration (FDA) has good news for you: in the future, you are less likely to be misinformed about the absence of this allergen in such products as medical devices. To avoid false assurances about this hazard, the FDA is recommending to manufacturers to stop using the labels “latex free” or “does not contain latex.” The reason for this recommendation is that the agency is not aware of any tests that can show a product contains no natural rubber latex proteins that can cause allergic reactions
Personal Protective Equipment
A recent increase in demand for personal protective equipment (PPE) has caused delays for some products ordered by U.S. hospitals for Ebola preparedness.
Ebola virus disease presents a unique occupational health challenge to healthcare institutions, and Ebola readiness and response can drain al-ready-scarce infection prevention resources. This is reflected in a recent survey of infection preventionists at U.S. hospitals conducted by the Association for Professionals in Infection Control and Epidemiology (APIC) in which only 6 percent of healthcare institutions are well-prepared to receive a patient with the Ebola virus. Infection preventionists everywhere are hoping that the Ebola crisis can shed new light on the importance of a properly funded and resourced department.
The Society for Healthcare Epidemiology of America (SHEA) says it is dedicated to the prevention of infection in healthcare settings, including the protection of healthcare personnel (HCP) who provide care to patients with known or suspe
The recent Ebola crisis has challenged the healthcare community to step up its preparedness for managing new cases of Ebola and other high-risk infectious diseases.
Today, Nov. 7, 2014, thousands of healthcare workers will participate in a large Ebola safety education session in Los Angeles.
The Centers for Disease Control and Prevention (CDC) has ordered $2.7 million in personal protective equipment (PPE) to increase Strategic National Stockpile (SNS) supplies to assist U.S. hospitals caring for Ebola patients. Products are being configured into 50 kits that can be rapidly delivered to hospitals. Each kit can provide the PPE needed by clinical teams to manage the care of one Ebola patient for up to five days.
One-third of America's safety-net facilities reported limited supplies of waterproof shoe covers, gowns, face shields, single-use respirators and other personal protective equipment (PPE) the Centers for Disease Control and Prevention rec